Omeros Corporation
OMER
#6930
Rank
S$0.89 B
Marketcap
S$12.31
Share price
-1.04%
Change (1 day)
164.57%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2026 (TTM): -S$30.81 Million

According to Omeros Corporation's latest financial reports the company's current earnings are S$9.89 Million. In 2025 the company made an earning of -S$0.15 Billion, an increase over its 2024 earnings that were of -S$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$30.81 Million-79.32%
2025 -S$0.15 Billion-27.03%
2024 -S$0.21 Billion9.63%
2023 -S$0.19 Billion-9.57%
2022 -S$0.21 Billion-30.65%
2021 -S$0.3 Billion86.28%
2020 -S$0.16 Billion99.45%
2019 -S$79.89 Million-49.91%
2018 -S$0.16 Billion190.77%
2017 -S$54.85 Million-27.96%
2016 -S$76.14 Million-17.61%
2015 -S$92.41 Million1.88%
2014 -S$90.71 Million87.56%
2013 -S$48.37 Million
2011 -S$35.42 Million-8.96%
2010 -S$38.9 Million45.03%
2009 -S$26.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.56 B-107,686.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.68 B-43,960.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-S$5 Million-83.99%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
-S$19.28 Million-38.22%๐Ÿ‡บ๐Ÿ‡ธ USA